Reuters logo
BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval
October 13, 2017 / 12:18 PM / a month ago

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

Oct 13(Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd

* Says it received approval for a kind of tablet, which is used for treatment of chronic hepatitis B, from U.S. Food and Drug Administration

* Says it will be able to sell the tablet in the United States after receiving the FDA approval

Source text in Chinese:

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below